Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Autoimmune Treatment Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Autoimmune Treatment Market, by Indication, 2020-2028 (USD Billion)
1.2.3. Global Autoimmune Treatment Market, by Drug Class, 2020-2028 (USD Billion)
1.2.4. Global Autoimmune Treatment Market, by Sales Channel, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Autoimmune Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Autoimmune Treatment Market Dynamics
3.1. Autoimmune Treatment Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rise in the prevalence of autoimmune diseases
3.1.1.2. Increasing investments in research and development
3.1.2. Market Challenges
3.1.2.1. Low medical insurance coverage for autoimmune diseases
3.1.3. Market Opportunities
3.1.3.1. Advancements in diagnostic methods
Chapter 4. Global Autoimmune Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Autoimmune Treatment Market, by Indication
6.1. Market Snapshot
6.2. Global Autoimmune Treatment Market by Indication, Performance - Potential Analysis
6.3. Global Autoimmune Treatment Market Estimates & Forecasts by Indication 2019-2028 (USD Billion)
6.4. Autoimmune Treatment Market, Sub Segment Analysis
6.4.1. Rheumatic Disease
6.4.2. Diabetes
6.4.3. Multiple Sclerosis
6.4.4. Inflammatory Bowel Disease
6.4.5. Other Indications
Chapter 7. Global Autoimmune Treatment Market, by Drug Class
7.1. Market Snapshot
7.2. Global Autoimmune Treatment Market by Drug Class, Performance - Potential Analysis
7.3. Global Autoimmune Treatment Market Estimates & Forecasts by Drug Class 2019-2028 (USD Billion)
7.4. Autoimmune Treatment Market, Sub Segment Analysis
7.4.1. Anti-Inflammatory
7.4.2. Anti-Hyperglycemics
7.4.3. NSAIDs
7.4.4. Interferons
7.4.5. Other Drugs
Chapter 8. Global Autoimmune Treatment Market, by Sales Channel
8.1. Market Snapshot
8.2. Global Autoimmune Treatment Market by Sales Channel, Performance - Potential Analysis
8.3. Global Autoimmune Treatment Market Estimates & Forecasts by Sales Channel 2019-2028 (USD Billion)
8.4. Autoimmune Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacy
8.4.2. Online
8.4.3. Others
Chapter 9. Global Autoimmune Treatment Market, Regional Analysis
9.1. Autoimmune Treatment Market, Regional Market Snapshot
9.2. North America Autoimmune Treatment Market
9.2.1. U.S. Autoimmune Treatment Market
9.2.1.1. Indication estimates & forecasts, 2019-2028
9.2.1.2. Drug Class estimates & forecasts, 2019-2028
9.2.1.3. Sales Channel estimates & forecasts, 2019-2028
9.2.2. Canada Autoimmune Treatment Market
9.3. Europe Autoimmune Treatment Market Snapshot
9.3.1. U.K. Autoimmune Treatment Market
9.3.2. Germany Autoimmune Treatment Market
9.3.3. France Autoimmune Treatment Market
9.3.4. Spain Autoimmune Treatment Market
9.3.5. Italy Autoimmune Treatment Market
9.3.6. Rest of Europe Autoimmune Treatment Market
9.4. Asia-Pacific Autoimmune Treatment Market Snapshot
9.4.1. China Autoimmune Treatment Market
9.4.2. India Autoimmune Treatment Market
9.4.3. Japan Autoimmune Treatment Market
9.4.4. Australia Autoimmune Treatment Market
9.4.5. South Korea Autoimmune Treatment Market
9.4.6. Rest of Asia Pacific Autoimmune Treatment Market
9.5. Latin America Autoimmune Treatment Market Snapshot
9.5.1. Brazil Autoimmune Treatment Market
9.5.2. Mexico Autoimmune Treatment Market
9.6. Rest of The World Autoimmune Treatment Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Autoimmune Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Siemens Healthcare Private Limited
10.2.3. LUPIN.
10.2.4. Thermo Fisher Scientific Inc
10.2.5. Merck Sharp & Dohme Corp
10.2.6. Bristol-Myers Squibb Company
10.2.7. AstraZeneca
10.2.8. Pfizer Inc.
10.2.9. Johnson & Johnson Services, Inc.
10.2.10. Abbott
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption